BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Novasep Invests €10M in “SeneFill”, Its New Facility for Commercial Aseptic Fill & Finish Operations

  Novasep announces a EUR10M investment in a commercial fill & finish facility for viral vectors, mAbs and other low-volume biologics.

  May 3, 2018

   · 

  1 min read
• Business

  DermTech Announces Melanoma Research Foundation Walk Support

  DermTech, Inc. announced it is partnering with the Melanoma Research Foundation in support of five Miles for Melanoma Run/Walks held throughout the US, kicking off this month during Melanoma Awareness Month.

  May 3, 2018

   · 

  2 min read
• Business

  West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences

  West Pharmaceutical Services, Inc. announced that the Company’s Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.

  May 3, 2018

   · 

  2 min read
• Biotech Bay

  Pharmaceutical Patent Litigation Increases Nearly 30 Percent in 2017: Lex Machina Releases Fourth Hatch-Waxman/ANDA Litigation Report

  Lex Machina announced the release of its fourth annual Hatch-Waxman/ANDA Litigation Report.

  May 3, 2018

   · 

  5 min read
• FDA

  Exact Imaging Receives FDA 510(k) Clearance for Adding the FusionVu Application to the ExactVu Micro-Ultrasound Platform

  Exact Imaging announced it has received FDA 510(k) Clearance for its FusionVu™ application on the ExactVu micro-ultrasound system.

  May 3, 2018

   · 

  2 min read
• Genetown

  Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies

  Casma Therapeutics, Inc. launched with $58.5 million in Series A funding from Third Rock Ventures.

  May 3, 2018

   · 

  5 min read
• Pharm Country

  Technical Perspectives on Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma

  WallStEquities.com is offering reports on AGN, CPRX, FLXN, and SUPN which can be accessed for free by signing up to www.wallstequities.com/registration.

  May 3, 2018

   · 

  7 min read
• Business

  Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness

  Sage Therapeutics, Inc. reported business highlights and financial results for the first quarter ended March 31, 2018.

  May 3, 2018

   · 

  15 min read
• Pharm Country

  Stock Review for Biotech’s Investors -- BioTime, Eleven Biotherapeutics, Endocyte, and Esperion Therapeutics

  WallStEquities.com is offering reports on BTX, EBIO, ECYT, and ESPR which can be accessed for free by signing up to www.wallstequities.com/registration.

  May 3, 2018

   · 

  6 min read
• Business

  Cardinal Health Reports Third-quarter Results for Fiscal Year 2018

  Cardinal Health (NYSE:CAH) today reported third-quarter fiscal year 2018 revenue of $33.6 billion, an increase of 6 percent.

  May 3, 2018

   · 

  54 min read